Neuroscience Discovery & Alternatives to Opioids

Join us November 14 in the Greater Cincinnati area

Opioid abuse is among the deadliest population health crises in America, with more than 14 opioid-related overdose deaths each day in Ohio. Thanks to the determination of dedicated individuals, real change is happening, lives are transforming, and diverse community partners and caring professionals are making a difference.

This conference will highlight Ohio technologies that are addressing this crisis. In addition to amazing speakers and stakeholders addressing the current state of Ohio’s epidemic, this event will host companies with a product or service addressing this crisis. Join us and be part of the solution.

This regional event is held in partnership with BioOhio’s fellow statewide bioscience organizations, Indiana Health Industry Forum and the Kentucky Life Sciences Council. IHIF and KLSC members can register using the BioOhio member rate.

Click here to learn about our speakers!

Alternatives to Opioids Tech Showcase

Looking for a way to showcase your company product or service? Apply to exhibit now and join innovators from around Ohio presenting their latest technologies. Space is limited – don’t miss out on your opportunity to gain visibility for your company and to meet others in the industry!

Exhibitor rate: $300. Price includes 1 registration, table space, and name/logo visibility throughout the event.

Agenda Topics

8:15 am – Registration, Breakfast, Networking & Tech Showcase

9:00 – Welcome & Opening Remarks from John F. Lewis Jr., President & CEO, BioOhio

9:10 – Keynote: The Landscape and Future of Neuroscience Discovery

Moderated by Jill Schiaparelli, Chief Operating Officer, Neurotechnology Innovations Translator | CEO, Veressa Medical
Joseph Broderick, MD, Professor of Neurology, Director, University of Cincinnati Gardner Neuroscience Institute
Ali Rezai, MD, Director, Rockefeller Neuroscience Institute | Associate Dean; John D. Rockefeller IV tenured professor in neuroscience, West Virginia University

10:10 – Incubator and Investor Panel for Neuroscience Discovery

Moderated by John F. Lewis Jr., President & CEO, BioOhio
Jill Schiaparelli, Chief Operating Officer, Neurotechnology Innovations Translator | CEO, Veressa Medical
Charles Steiner, Director, Business & Product Development | Innovations, Cleveland Clinic
Ohio Third Frontier (invited) to discuss funding options, like the “Ohio Opioid Abuse, Prevention and Treatment Technology Initiative” designed to accelerate the development and commercialization of promising new products (or adaptations or modifications) in the categories of medical devices, diagnostics, pharmaceuticals, and health technology

11:00 – Networking Break & Tech Showcase

11:15 – Innovations that Impact Lives, the Future of Neuroscience (Research Focused)

Jonathan Cachat, PhD., Director of Laboratory Sciences Program, Hocking College | President & CEO, CCV Research
Clay Marsh, MD, Vice President and Executive Dean Health Sciences, West Virginia University

12:30 pm – Networking Lunch & Tech Showcase

1:15 – Keynote Conversation: Investing in Community Addiction Recovery

Moderated by Phyllis Grauer, PharmD, BCGP, CPE, CDCA, Owner, Specialty Practice Clinical Consultant, ChaRxis Consulting
Ben Ertel, Business Development, Hotel California by the Sea | Board Member, The Ohio Citizen Advocates for Addiction Recovery
Benjamin Glassman, United States Attorney, Southern District of Ohio
Randy Jernejcic, MD, MMM, Vice President of Clinical Integration, University Hospitals | First Physician Chair, Northeast Ohio Hospital Opioid Consortium
Sarah Nerad, MPA, Associate Director of Community Relations, Alkermes

2:15 – Networking Break & Tech Showcase

2:30 – Pain Management: Alternatives to Opioids

Moderated by Solomon Wilcots, Former Cincinnati Bengal | Radio Talk Show Host at Sirius XM Inc.| NFL Analyst at Sky Sports UK | Leader of Sports/Health public relations initiatives at Russo Partners Sports – Health Alliance
Gregory Fiore, MD, President and Chief Executive Officer, Sollis Therapeutics
Chandu Kasibhatla, PhD, MBA, Associate Director, Medical Affairs, US WorldMeds
Adam Link, Director, Pain Management Therapy Development, AtriCure
Brad Pulver, President, Innovative Medical Equipment
Jon Snyder, Founder, Chief Business Officer, Neuros Medical